{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T17:26:41Z","timestamp":1771003601627,"version":"3.50.1"},"reference-count":101,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","seminarsinnephrology.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.semnephrol.2016.02.005","type":"journal-article","created":{"date-parts":[[2016,5,25]],"date-time":"2016-05-25T23:00:19Z","timestamp":1464217219000},"page":"112-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Safety Issues in Iron Treatment in CKD"],"prefix":"10.1016","volume":"36","author":[{"given":"Nosratola D.","family":"Vaziri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2016.02.005_bib1","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJM199808273390903","article-title":"The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin","volume":"339","author":"Besarab","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib2","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa062276","article-title":"Normalization of hemoglobin level in patients with chronic kidney disease and anemia","volume":"355","author":"Drueke","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib3","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJMoa065485","article-title":"Correction of anemia with epoetin alfa in chronic kidney disease","volume":"355","author":"Singh","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib4","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/ki.2008.295","article-title":"Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes","volume":"74","author":"Szczech","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib5","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1681\/ASN.2010020173","article-title":"Naturally occurring higher hemoglobin concentration does not increase mortality among hemodialysis patients","volume":"22","author":"Goodkin","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib6","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.2215\/CJN.02600315","article-title":"Understanding the recent increase in ferritin levels in United States dialysis patients: potential impact of changes in intravenous iron and erythropoiesis-stimulating agent dosing","volume":"10","author":"Karaboyas","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib7","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1046\/j.1523-1755.2002.00600.x","article-title":"The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia","volume":"62","author":"Himmelfarb","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1440-1797.2006.00541.x","article-title":"Inflammation in end-stage renal disease: the hidden enemy","volume":"11","author":"Stenvinkel","year":"2006","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib9","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1111\/j.1523-1755.2004.00580.x","article-title":"The effects of iron dextran on the oxidative stress in cardiovascular tissues of rats with chronic renal failure","volume":"65","author":"Lim","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib10","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.semnephrol.2004.06.026","article-title":"Oxidative stress in uremia: nature, mechanisms, and potential consequences","volume":"24","author":"Vaziri","year":"2004","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib11","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ncpneph0847","article-title":"Anemia and anemia correction: surrogate markers or causes of morbidity in chronic kidney disease?","volume":"4","author":"Vaziri","year":"2008","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib12","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/ndt\/gfn601","article-title":"Potential mechanisms of adverse outcomes in trials of anemia correction with erythropoietin in chronic kidney disease","volume":"24","author":"Vaziri","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib13","first-page":"114","article-title":"Iron sucrose promotes endothelial injury and dysfunction and monocyte adhesion\/infiltration","volume":"29","author":"Kamanna","year":"2011","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib14","doi-asserted-by":"crossref","first-page":"e0125272","DOI":"10.1371\/journal.pone.0125272","article-title":"Comparative evaluation of nephrotoxicity and management by macrophages of intravenous pharmaceutical iron formulations","volume":"10","author":"Connor","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib15","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1038\/labinvest.3780200","article-title":"Association of renal injury with increased oxygen free radical activity and altered nitric oxide metabolism in chronic experimental hemosiderosis","volume":"80","author":"Zhou","year":"2000","journal-title":"Lab Invest"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10534-007-9104-9","article-title":"Iron-induced oxidative stress in haemodialysis patients: a pilot study on the impact of diabetes","volume":"21","author":"Van Campenhout","year":"2008","journal-title":"Biometals"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib17","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1681\/ASN.2007101084","article-title":"Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients","volume":"19","author":"Kuo","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib18","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1440-1797.2009.01174.x","article-title":"Randomized clinical trial on acute effects of i.v. iron sucrose during haemodialysis","volume":"15","author":"Garcia-Fernandez","year":"2010","journal-title":"Nephrology"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib19","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/ki.2015.163","article-title":"A randomized trial of intravenous and oral iron in chronic kidney disease","volume":"88","author":"Agarwal","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib20","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1681\/ASN.2013080838","article-title":"Iron sucrose accelerates early atherogenesis by increasing superoxide production and upregulating adhesion molecules in CKD","volume":"25","author":"Kuo","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib21","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1093\/ndt\/gfl341","article-title":"Apoptotic stress pathway activation mediated by iron on endothelial cells in vitro","volume":"21","author":"Carlini","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 1","key":"10.1016\/j.semnephrol.2016.02.005_bib22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2362.2002.0320s1009.x","article-title":"Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo","volume":"32","author":"Rooyakkers","year":"2002","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib23","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1681\/ASN.V103594","article-title":"Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease","volume":"10","author":"Kielstein","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib24","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(01)07217-8","article-title":"Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study","volume":"358","author":"Zoccali","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib25","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1161\/01.CIR.0000035250.66458.67","article-title":"Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease","volume":"106","author":"Dr\u00fceke","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib26","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1536\/ihj.46.255","article-title":"Intravenous iron therapy as a possible risk factor for atherosclerosis in end stage renal disease","volume":"46","author":"Reis","year":"2005","journal-title":"Int Heart J"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib27","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.freeradbiomed.2005.01.008","article-title":"The iron chelator desferrioxamine inhibits atherosclerotic lesion development and decreases lesion iron concentrations in the cholesterol-fed rabbit","volume":"38","author":"Minqin","year":"2005","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib28","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0891-5849(02)01427-2","article-title":"Correlation of iron and zinc levels with lesion depth in newly formed atherosclerotic lesions","volume":"34","author":"Minqin","year":"2003","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib29","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1161\/ATVBAHA.115.305586","article-title":"Aortic iron overload with oxidative stress and inflammation in human and murine abdominal aortic aneurysm","volume":"35","author":"Sawada","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib30","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1161\/01.ATV.0000124892.90999.cb","article-title":"Direct detection and quantification of transition metal ions in human atherosclerotic plaques: evidence for the presence of elevated levels of iron and copper","volume":"24","author":"Stadler","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib31","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.freeradbiomed.2005.05.006","article-title":"Foam cell death induced by 7beta-hydroxycholesterol is mediated by labile iron-driven oxidative injury: mechanisms underlying induction of ferritin in human atheroma","volume":"39","author":"Li","year":"2005","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib32","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1096\/fj.06-6114com","article-title":"Cytocidal effects of atheromatous plaque components: the death zone revisited","volume":"20","author":"Li","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib33","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1161\/01.ATV.14.2.299","article-title":"Antiproliferative effect of desferrioxamine on vascular smooth muscle cells in vitro and in vivo","volume":"14","author":"Porreca","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib34","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/ndt\/gfq858","article-title":"Iron and vascular calcification","volume":"26","author":"Neven","year":"2011","journal-title":"Is there a link? Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib35","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.jrn.2011.10.020","article-title":"Effect of uremia on function and structure of immune system","volume":"22","author":"Vaziri","year":"2012","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib36","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nrneph.2010.36","article-title":"HDL metabolism and activity in chronic kidney disease","volume":"6","author":"Vaziri","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib37","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000321845","article-title":"Lipid disorders and their relevance to outcomes in chronic kidney disease","volume":"31","author":"Vaziri","year":"2011","journal-title":"Blood Purif"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib38","article-title":"Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment","author":"Vaziri","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib39","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/sj.ki.5002019","article-title":"Spontaneous leukocyte activation and oxygen-free radical generation in end-stage renal disease","volume":"71","author":"Yoon","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib40","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000276764","article-title":"Leukocyte toll-like receptor expression in end-stage kidney disease","volume":"31","author":"Gollapudi","year":"2010","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib41","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1681\/ASN.2008070734","article-title":"Oxidized LDL modulates apoptosis of regulatory T cells in patients with ESRD","volume":"20","author":"Meier","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib42","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00041552-200401000-00013","article-title":"Roles of oxidative stress and antioxidant therapy in chronic renal disease and hypertension","volume":"13","author":"Vaziri","year":"2004","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib43","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/ndt\/gfp580","article-title":"Effects of end-stage renal disease and haemodialysis on dendritic cell subsets and basal and LPS-stimulated cytokine production","volume":"25","author":"Agrawal","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib44","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/sj.ki.5001550","article-title":"Na\u0131ve and central memory T-cell lymphopenia in end-stage renal disease","volume":"70","author":"Yoon","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib45","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/ndt\/gfp397","article-title":"Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression","volume":"25","author":"Pahl","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib46","doi-asserted-by":"crossref","first-page":"S186","DOI":"10.1046\/j.1523-1755.2001.59780186.x","article-title":"Defects in B-cell function and metabolism in uremia: role of parathyroid hormone","volume":"78","author":"Smogorzewski","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib47","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1440-1797.2008.01041.x","article-title":"Decreased CD3+CD16+ natural killer-like T-cell percentage and zeta-chain expression accompany chronic inflammation in hemodialysis patients","volume":"14","author":"Liakopoulos","year":"2009","journal-title":"Nephrology"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib48","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/ndt\/gfm596","article-title":"Natural killer cell alterations correlate with loss of renal function and dialysis duration in hemodialysis patients","volume":"23","author":"Vacher-Coponat","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib49","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000168284","article-title":"Impaired phagocytosis in dialysis patients: studies on mechanisms","volume":"11","author":"Alexiewicz","year":"1991","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib50","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.1046\/j.1523-1755.2001.59780195.x","article-title":"Dysfunction of polymorphonuclear leukocytes in uremia: role of parathyroid hormone","volume":"78","author":"Massry","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib51","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1079\/BJN2001366","article-title":"Reduced thymocyte proliferation but not increased apoptosis as a possible cause of thymus atrophy in iron-deficient mice","volume":"86","author":"Kuvibidila","year":"2001","journal-title":"Br J Nutr"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib52","first-page":"RA19","article-title":"Pathogenetic aspects of immune deficiency associated with betathalassemia","volume":"9","author":"Farmakis","year":"2003","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib53","doi-asserted-by":"crossref","first-page":"4707","DOI":"10.3748\/wjg.v13.i35.4707","article-title":"Iron overload and immunity","volume":"13","author":"Porto","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib54","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0167-4889(92)90062-G","article-title":"Uptake and intracellular handling of iron from transferrin and iron chelates by mitogen stimulated mouse lymphocytes","volume":"1133","author":"Djeha","year":"1992","journal-title":"Biochem Biophys Acta"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib55","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2369-11-16","article-title":"Effect of different intravenous iron preparations on lymphocyte intracellular reactive oxygen species generation and subpopulation survival","volume":"11","author":"Gupta","year":"2010","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib56","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1046\/j.1523-1755.2003.00125.x","article-title":"High dose parenteral iron sucrose depresses neutrophil intracellular killing capacity","volume":"64","author":"Deicher","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib57","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1681\/ASN.V94655","article-title":"Neutrophil impairment associated with iron therapy in hemodialysis patients with functional iron deficiency","volume":"9","author":"Patruta","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib58","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0163-4453(84)93955-0","article-title":"Functional defects in phagocytic cells from patients with iron overload","volume":"8","author":"van Asbeck","year":"1984","journal-title":"J Infect"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib59","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1136\/bmj.291.6494.501","article-title":"Impaired phagocytic activity of neutrophils in patients receiving haemodialysis: The critical role of iron overload","volume":"291","author":"Waterlot","year":"1985","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib60","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1742-1241.2008.01732.x","article-title":"Intravenous iron attenuates postvaccination anti-HBsAg titers after quadruple hepatitis B vaccination in dialysis patients with erythropoietin therapy","volume":"63","author":"Liu","year":"2009","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib61","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1055\/s-2007-1007220","article-title":"Iron in liver diseases other than hemochromatosis","volume":"16","author":"Bonkovsky","year":"1996","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib62","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1086\/428062","article-title":"Association of hepatitis C virus infection with serum iron status: analysis of data from the third National Health and Nutrition Examination Survey","volume":"40","author":"Shan","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib63","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.vetmic.2015.03.024","article-title":"Interplay between iron homeostasis and virulence: Fur and RyhB as major regulators of bacterial pathogenicity","volume":"179","author":"Porcheron","year":"2015","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib64","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1681\/ASN.2012121164","article-title":"Infection risk with bolus versus maintenance iron supplementation in hemodialysis patients","volume":"24","author":"Brookhart","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib65","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10534-011-9409-6","article-title":"Non-transferrin bound iron, cytokine activation and intracellular reactive oxygen species generation in hemodialysis patients receiving intravenous iron dextran or iron sucrose","volume":"24","author":"Pai","year":"2011","journal-title":"Biometals"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib66","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1172\/JCI44490","article-title":"An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice","volume":"121","author":"Sindrilaru","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib67","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib68","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nri978","article-title":"Alternative activation of macrophages","volume":"3","author":"Gordon","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib69","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1182\/blood-2007-12-077917","article-title":"The phagocytes: neutrophils and monocytes","volume":"112","author":"Dale","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib70","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJM200008033430503","article-title":"Hepatic iron concentration and total body iron stores in thalassemia major","volume":"343","author":"Angelucci","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib71","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1523-1755.2004.00480.x","article-title":"Validation of serum ferritin values by magnetic susceptometry in predicting iron overload in dialysis patients","volume":"65","author":"Canavese","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib72","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2215\/CJN.04190510","article-title":"Serum iron markers are inadequate for guiding iron repletion in chronic kidney disease","volume":"6","author":"Ferrari","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2012.01.015","article-title":"Hemodialysis-associated hemosiderosis in the era of erythropoiesis-stimulating agents: a MRI study","volume":"125","author":"Rostoker","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib74","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.blre.2008.03.001","article-title":"Current approach to hemochromatosis","volume":"22","author":"Brissot","year":"2008","journal-title":"Blood Rev"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib75","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s10620-007-9945-7","article-title":"Phlebotomy improves therapeutic response to interferon in patients with chronic hepatitis C: a meta-analysis of six prospective randomized controlled trials","volume":"53","author":"Desai","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib76","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2011.01.053","article-title":"Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C","volume":"140","author":"Lambrecht","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib77","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.2337\/dc06-2625","article-title":"The role of iron in diabetes and its complications","volume":"30","author":"Swaminathan","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib78","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.2337\/diab.46.11.1733","article-title":"Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells","volume":"46","author":"Tiedge","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib79","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S1357-2725(99)00065-5","article-title":"The iron transporter DMT1","volume":"31","author":"Andrews","year":"1999","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib80","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1046\/j.1365-2265.2003.01729.x","article-title":"A relationship between serum ferritin and the insulin resistance syndrome is present in non-diabetic women but not in non-diabetic men","volume":"58","author":"Sheu","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib81","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.2337\/dc06-0119","article-title":"Iron intake and the risk of type 2 diabetes in women: a prospective cohort study","volume":"29","author":"Rajpathak","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib82","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.2337\/diacare.27.10.2422","article-title":"Serum ferritin and risk of the metabolic syndrome in U.S. adults","volume":"27","author":"Jehn","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib83","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.2337\/diacare.28.8.2061","article-title":"Prevalence of body iron excess in the metabolic syndrome","volume":"28","author":"Bozzini","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib84","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.2337\/dc06-0164","article-title":"Association of elevated serum ferritin levels and the risk of gestational diabetes mellitus in pregnant women: the Camden study","volume":"29","author":"Chen","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib85","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.2337\/diabetes.51.4.1000","article-title":"Blood letting in high-ferritin type 2 diabetes: effects on insulin sensitivity and beta-cell function","volume":"51","author":"Fernandez-Real","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib86","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/0026-0495(94)90204-6","article-title":"Response to repeated phlebotomies in patients with non-insulin-dependent diabetes mellitus","volume":"43","author":"Bofill","year":"1994","journal-title":"Metabolism"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib87","doi-asserted-by":"crossref","first-page":"650","DOI":"10.2337\/diacare.27.3.650","article-title":"Impact of iron deficiency anemia on prevalence of gestational diabetes mellitus","volume":"27","author":"Lao","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib88","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1006\/bbrc.1998.9326","article-title":"Transition metals bind to glycated proteins forming redox active \u201cglycochelates\u201d: implications for the pathogenesis of certain diabetic complications","volume":"250","author":"Qian","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib89","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0891-5849(94)00202-U","article-title":"The effects of desferrioxamine and ascorbate on oxidative stress in the streptozotocin diabetic rat","volume":"18","author":"Young","year":"1995","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib90","first-page":"S18","article-title":"Role of oxidative stress in the development of diabetic nephropathy","volume":"51","author":"Ha","year":"1995","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib91","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1681\/ASN.2006050500","article-title":"Oxidants in chronic kidney disease","volume":"18","author":"Shah","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib92","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/15376516.2012.730558","article-title":"Effect of deferiprone, an oral iron chelator, in diabetic and non-diabetic glomerular disease","volume":"23","author":"Rajapurkar","year":"2013","journal-title":"Toxicol Mech Methods"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib93","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/ki.2010.336","article-title":"Dementia and cognitive impairment in ESRD: diagnostic and therapeutic strategies","volume":"79","author":"Kurella Tamura","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib94","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1212\/01.WNL.0000149519.47454.F2","article-title":"Midlife cardiovascular risk factors and risk of dementia in late life","volume":"64","author":"Whitmer","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib95","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1212\/WNL.56.12.1683","article-title":"Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study","volume":"56","author":"Kivipelto","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib96","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1212\/WNL.56.1.42","article-title":"Cardiovascular risk factors and cognitive decline in middle-aged adults","volume":"56","author":"Knopman","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib97","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00204-010-0577-x","article-title":"Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson\u2019s, Huntington\u2019s, Alzheimer\u2019s, prions, bactericides, chemical toxicology and others as examples","volume":"84","author":"Kell","year":"2010","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib98","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1681\/ASN.V1291892","article-title":"Increased tyrosine nitration of the brain in chronic renal insufficiency: reversal by antioxidant therapy and angiotensin-converting enzyme inhibition","volume":"12","author":"Deng","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib99","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1542-4758.2006.00107.x","article-title":"Effect of improvement in anemia on electroneurophysiological markers (P300) of cognitive dysfunction in chronic kidney disease","volume":"10","author":"Singh","year":"2006","journal-title":"Hemodial Int"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib100","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/S0272-6386(99)70150-2","article-title":"Normalizing hematocrit in dialysis patients improves brain function","volume":"33","author":"Pickett","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2016.02.005_bib101","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1744-9987.2010.00836.x","article-title":"2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease","volume":"14","author":"Tsubakihara","year":"2010","journal-title":"Ther Apher Dial"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929516000164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929516000164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T15:40:19Z","timestamp":1656603619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929516000164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":101,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0270929516000164"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2016.02.005","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety Issues in Iron Treatment in CKD","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2016.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}